I'm not sure if there's value in COVID vaccines, I mean there's been millions distributed at optimal temps presumably without any issue. With the sale price of the vaccines so slow the cost of this tech is quite high proportionately. I think driving costs lower will be the focus as we shift to logistical hurdles in developing worlds (which are yet to catch up with vaccinations).
Happy to be challenged / proven otherwise
Ann: Bluechiip and Labcon reach US$1.6m settlement, page-21
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BCT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.616M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| BCT (ASX) Chart |
Day chart unavailable